T0	SampleSize 23588 23609	small patient numbers
T1	UnderpoweredStudy 23625 23683	was not powered to detect differences in clinical outcomes
T2	VerySpecificPopulation 23685 23738	Our significant proportion of cardiovascular patients
T3	Generalization 23748 23770	limit generalizability
T4	HighLossToFollowUp 24002 24121	Our loss to follow-up for our functional secondary outcomes measured at ICU and hospital discharge was also significant
T5	MissingData 24196 24272	data collection on nutrition intake ceased when oral intake commenced in ICU
T6	ValidityOfMeasurement 23772 23880	We used ‘administration of new antibiotics’ as a surrogate marker for development of infective complications
